Slide background

April 7–8
Basel, Switzerland

Novel Antimicrobials & AMR Diagnostics

6th AMR Conference

AMR Conference

7–8 April 2022, Basel

Thank you to our sponsors, partners and all participants!


The #AMRconference 2020 was a great success. Almost 450 international AMR experts have participated in 26 live sessions which provided a 360 degree overview of the current AMR industry and resulted in engaging discussions.

We look forward to welcoming you again in summer 2021 – hopefully face-to-face.

Here are some key takeaways from the Closing Session:

Play Video

What you can expect

The AMR Conference is a platform to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to market.

More than 400 participants from 25+ countries

High-level panels and expert sessions > live and on-demand

Scientific poster presentations

A wide variety of topics from financing, development & regulation

Virtual 1:1 partnering meetings

SMEs, academics & governmental agencies benefit from discounted fees

2019 Event Highlights

Event Impressions & Testimonials

More than 330 experts joined the 2-day AMR Conference 2019 in Berlin. They called for rapid capital investments and economic incentives in the fight against antimicrobial resistance (AMR). The AMR Conference is a platform for SMEs, start-ups, big pharma, academia, clinicians, investors, public stakeholders and policy-makers to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

Latest News

in the AMR and antimicrobial space

CARB-X receives additional US$ 370m from US Government and Wellcome Trust

CARB-X (part of Boston University) announces the renewal of its support from Wellcome Trust, a worldwide…

Vivli awarded contract by Wellcome Trust to improve use of AMR surveillance data

The availability of surveillance data on antimicrobial resistance (AMR) makes it possible to assess incidence rates…

COVID-19 pandemic may be accelerating antimicrobial resistance: new US study published

A new study by BD (Becton Dickinson) and MSD (Merck & Co.) found higher rates of…

We thank our Sponsors & Partners

Supporting Partners

Media Partners